tiprankstipranks
Zimmer Biomet Holdings (CH:ZBH)
:ZBH
Switzerland Market
ZBH
Zimmer Biomet Holdings
RESEARCH TOOLSreports

Zimmer Biomet Holdings (ZBH) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

ZBH Analyst Ratings

Moderate Buy
18Ratings
Moderate Buy
6 Buy
12 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Zimmer
Biomet Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZBH Stock 12 Month Forecast

Average Price Target

CHF86.11
▲(9.69% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is CHF86.11 with a high forecast of CHF97.42 and a low forecast of CHF75.50. The average price target represents a 9.69% change from the last price of CHF78.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"63":"CHF63","98":"CHF98","71.75":"CHF71.8","80.5":"CHF80.5","89.25":"CHF89.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":97.4220504,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF97.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":86.11026788133333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF86.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.50208906,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF75.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[63,71.75,80.5,89.25,98],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,75.5,77.18631156923077,78.87262313846153,80.55893470769232,82.24524627692308,83.93155784615385,85.61786941538462,87.30418098461539,88.99049255384615,90.67680412307692,92.3631156923077,94.04942726153847,95.73573883076924,{"y":97.4220504,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,75.5,76.31617445241025,77.13234890482052,77.94852335723077,78.76469780964102,79.58087226205129,80.39704671446154,81.21322116687179,82.02939561928204,82.84557007169231,83.66174452410256,84.47791897651281,85.29409342892308,{"y":86.11026788133333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,75.5,75.50016069692307,75.50032139384615,75.50048209076922,75.50064278769231,75.50080348461539,75.50096418153846,75.50112487846154,75.50128557538461,75.50144627230769,75.50160696923078,75.50176766615385,75.50192836307693,{"y":75.50208906,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":71.244,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.244,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.434,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.859,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.859,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.048,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.628,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.573,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.301,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.32,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.32,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.5,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF97.42Average Price TargetCHF86.11Lowest Price TargetCHF75.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:ZBH
Robbie Marcus
J.P. Morgan
J.P. Morgan
CHF94.99
Hold
21.00%
Upside
Reiterated
08/17/26
J.P. Morgan Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
Citi Analyst forecast on CH:ZBH
Joanne Wuensch
Citi
Citi
CHF80.37
Hold
2.39%
Upside
Reiterated
08/13/26
Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (NASDAQ: AVBP), Zimmer Biomet Holdings (NYSE: ZBH) and Tecan Group AG (Other OTC: TCHBF)
Truist Financial Analyst forecast on CH:ZBH
Richard Newitter
Truist Financial
Truist Financial
CHF86.06
Hold
9.63%
Upside
Reiterated
08/11/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (NASDAQ: CGON) and Zimmer Biomet Holdings (NYSE: ZBH)
Bank of America Securities Analyst forecast on CH:ZBH
Travis Steed
Bank of America Securities
Bank of America Securities
CHF16.24→CHF89.3
Hold
13.76%
Upside
Reiterated
08/11/26
Bank of America Securities Remains a Hold on Zimmer Biomet Holdings (ZBH)
Canaccord Genuity Analyst forecast on CH:ZBH
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
CHF67.38→CHF81.19
Buy
3.42%
Upside
Reiterated
08/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
William Blair Analyst forecast on CH:ZBH
Steven Lichtman
William Blair
William Blair
―
Hold
―
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Enliven Therapeutics (NASDAQ: ELVN) and Encompass Health (NYSE: EHC)
Robert W. Baird Analyst forecast on CH:ZBH
Jeff Johnson
Robert W. Baird
Robert W. Baird
CHF74.69→CHF84.43
Hold
7.56%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $104 from $92 at BairdZimmer Biomet price target raised to $104 from $92 at Baird
Deutsche Bank Analyst forecast on CH:ZBH
Pito Chickering
Deutsche Bank
Deutsche Bank
CHF71.44→CHF79.56
Hold
1.35%
Upside
Reiterated
08/06/26
Deutsche Bank Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
Wells Fargo Analyst forecast on CH:ZBH
Larry Biegelsen
Wells Fargo
Wells Fargo
CHF73.07→CHF83.62
Hold
6.52%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Cytek Biosciences (NASDAQ: CTKB) and Sight Sciences (NASDAQ: SGHT)
BMO Capital Analyst forecast on CH:ZBH
Vik Chopra
BMO Capital
BMO Capital
CHF77.13→CHF77.94
Hold
-0.72%
Downside
Reiterated
08/06/26
Zimmer Biomet price target raised to $96 from $95 at BMO CapitalZimmer Biomet price target raised to $96 from $95 at BMO Capital
Stifel Nicolaus Analyst forecast on CH:ZBH
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
CHF85.24→CHF89.3
Buy
13.76%
Upside
Assigned
08/06/26
Zimmer Biomet Holdings (ZBH) Receives a Buy from Stifel Nicolaus
Bernstein Analyst forecast on CH:ZBH
Lee Hambright
Bernstein
Bernstein
CHF73.88→CHF75.5
Hold
-3.82%
Downside
Reiterated
08/06/26
Zimmer Biomet Holdings (ZBH) Gets a Hold from Bernstein
UBS Analyst forecast on CH:ZBH
Patrick Wood
UBS
UBS
CHF93.36→CHF97.42
Buy
24.10%
Upside
Reiterated
08/06/26
UBS Remains a Buy on Zimmer Biomet Holdings (ZBH)
Needham Analyst forecast on CH:ZBH
Michael Matson
Needham
Needham
―
Hold
―
Reiterated
08/05/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN), Zimmer Biomet Holdings (NYSE: ZBH) and Recursion Pharmaceuticals (NASDAQ: RXRX)
TD Cowen Analyst forecast on CH:ZBH
Mathew Blackman
TD Cowen
TD Cowen
CHF88.49→CHF93.36
Buy
18.93%
Upside
Reiterated
08/05/26
Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:ZBH
Robbie Marcus
J.P. Morgan
J.P. Morgan
CHF94.99
Hold
21.00%
Upside
Reiterated
08/17/26
J.P. Morgan Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
Citi Analyst forecast on CH:ZBH
Joanne Wuensch
Citi
Citi
CHF80.37
Hold
2.39%
Upside
Reiterated
08/13/26
Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (NASDAQ: AVBP), Zimmer Biomet Holdings (NYSE: ZBH) and Tecan Group AG (Other OTC: TCHBF)
Truist Financial Analyst forecast on CH:ZBH
Richard Newitter
Truist Financial
Truist Financial
CHF86.06
Hold
9.63%
Upside
Reiterated
08/11/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (NASDAQ: CGON) and Zimmer Biomet Holdings (NYSE: ZBH)
Bank of America Securities Analyst forecast on CH:ZBH
Travis Steed
Bank of America Securities
Bank of America Securities
CHF16.24→CHF89.3
Hold
13.76%
Upside
Reiterated
08/11/26
Bank of America Securities Remains a Hold on Zimmer Biomet Holdings (ZBH)
Canaccord Genuity Analyst forecast on CH:ZBH
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
CHF67.38→CHF81.19
Buy
3.42%
Upside
Reiterated
08/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
William Blair Analyst forecast on CH:ZBH
Steven Lichtman
William Blair
William Blair
―
Hold
―
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Enliven Therapeutics (NASDAQ: ELVN) and Encompass Health (NYSE: EHC)
Robert W. Baird Analyst forecast on CH:ZBH
Jeff Johnson
Robert W. Baird
Robert W. Baird
CHF74.69→CHF84.43
Hold
7.56%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $104 from $92 at BairdZimmer Biomet price target raised to $104 from $92 at Baird
Deutsche Bank Analyst forecast on CH:ZBH
Pito Chickering
Deutsche Bank
Deutsche Bank
CHF71.44→CHF79.56
Hold
1.35%
Upside
Reiterated
08/06/26
Deutsche Bank Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
Wells Fargo Analyst forecast on CH:ZBH
Larry Biegelsen
Wells Fargo
Wells Fargo
CHF73.07→CHF83.62
Hold
6.52%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Cytek Biosciences (NASDAQ: CTKB) and Sight Sciences (NASDAQ: SGHT)
BMO Capital Analyst forecast on CH:ZBH
Vik Chopra
BMO Capital
BMO Capital
CHF77.13→CHF77.94
Hold
-0.72%
Downside
Reiterated
08/06/26
Zimmer Biomet price target raised to $96 from $95 at BMO CapitalZimmer Biomet price target raised to $96 from $95 at BMO Capital
Stifel Nicolaus Analyst forecast on CH:ZBH
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
CHF85.24→CHF89.3
Buy
13.76%
Upside
Assigned
08/06/26
Zimmer Biomet Holdings (ZBH) Receives a Buy from Stifel Nicolaus
Bernstein Analyst forecast on CH:ZBH
Lee Hambright
Bernstein
Bernstein
CHF73.88→CHF75.5
Hold
-3.82%
Downside
Reiterated
08/06/26
Zimmer Biomet Holdings (ZBH) Gets a Hold from Bernstein
UBS Analyst forecast on CH:ZBH
Patrick Wood
UBS
UBS
CHF93.36→CHF97.42
Buy
24.10%
Upside
Reiterated
08/06/26
UBS Remains a Buy on Zimmer Biomet Holdings (ZBH)
Needham Analyst forecast on CH:ZBH
Michael Matson
Needham
Needham
―
Hold
―
Reiterated
08/05/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN), Zimmer Biomet Holdings (NYSE: ZBH) and Recursion Pharmaceuticals (NASDAQ: RXRX)
TD Cowen Analyst forecast on CH:ZBH
Mathew Blackman
TD Cowen
TD Cowen
CHF88.49→CHF93.36
Buy
18.93%
Upside
Reiterated
08/05/26
Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zimmer Biomet Holdings

3 Months
Rick WiseStifel Nicolaus
Success Rate
15/29 ratings generated profit
52%
Average Return
+1.63%
Copying Rick Wise's trades and holding each position for 3 Months would result in 51.72% of your transactions generating a profit, with an average return of +1.63% per trade.
1 Year
Rick WiseStifel Nicolaus
Success Rate
16/29 ratings generated profit
55%
Average Return
+5.36%
Copying Rick Wise's trades and holding each position for 1 Year would result in 55.17% of your transactions generating a profit, with an average return of +5.36% per trade.
2 Years
Vijay KumarEvercore ISI
Success Rate
6/13 ratings generated profit
46%
Average Return
-0.52%
Copying Vijay Kumar's trades and holding each position for 2 Years would result in 46.15% of your transactions generating a profit, with an average return of -0.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZBH Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
11
7
6
5
10
Hold
21
16
17
10
22
Sell
4
1
1
0
0
Strong Sell
0
0
0
0
0
total
36
24
24
15
32
In the current month, ZBH has received 10 Buy Ratings, 22 Hold Ratings, and 0 Sell Ratings. ZBH average Analyst price target in the past 3 months is 86.11.
Each month's total comprises the sum of three months' worth of ratings.

ZBH Financial Forecast

ZBH Earnings Forecast

Next quarter’s earnings estimate for ZBH is CHF1.50 with a range of CHF1.49 to CHF1.53. The previous quarter’s EPS was CHF1.65. ZBH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.
Next quarter’s earnings estimate for ZBH is CHF1.50 with a range of CHF1.49 to CHF1.53. The previous quarter’s EPS was CHF1.65. ZBH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.

ZBH Sales Forecast

Next quarter’s sales forecast for ZBH is CHF1.63B with a range of CHF1.62B to CHF1.64B. The previous quarter’s sales results were CHF1.74B. ZBH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.
Next quarter’s sales forecast for ZBH is CHF1.63B with a range of CHF1.62B to CHF1.64B. The previous quarter’s sales results were CHF1.74B. ZBH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.

ZBH Stock Forecast FAQ

What is CH:ZBH’s average 12-month price target, according to analysts?
Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is 86.11.
    What is CH:ZBH’s upside potential, based on the analysts’ average price target?
    Zimmer Biomet Holdings has 9.69% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Zimmer Biomet Holdings a Buy, Sell or Hold?
          Zimmer Biomet Holdings has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 12 hold ratings and 0 sell ratings.
            What is Zimmer Biomet Holdings’s share price target?
            The average share price target for Zimmer Biomet Holdings is 86.11. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF97.42 ,and the lowest forecast is CHF75.50. The average share price target represents 9.69% Increase from the current price of CHF78.5.
              What do analysts say about Zimmer Biomet Holdings?
              Zimmer Biomet Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of Zimmer Biomet Holdings?
                To buy shares of CH:ZBH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.